PECAM1 and Alzheimer disease: To investigate if mCRP‐CD31 binding vs. ApoE‐CD31 binding are relevant to AD pathology, we used human temporal lobe tissues from 8 healthy controls and 10 AD patients (Figure 1, 2, 4, 5, 7, 8).